Acumen Pharmaceuticals, Inc. (ABOS) research

Acumen Pharmaceuticals, Inc.
ShareXLinkedInReddit
Sector
Healthcare
Industry
Biotechnology
Last price
$2.65
As of

Acumen Pharmaceuticals, Inc. (ABOS): 4 institutional managers tracked by Kresmion reported non-option positions in their 2026Q2 Form 13F filings, and the most recent SEC filing on record for the company is a Form 8-K filed 2026-09-16.

As of . Source: SEC EDGAR filings for ABOS. Method and limitations.

SHARE THIS CARD

Share the ABOS intelligence card

A branded snapshot of ABOS: the smart money composite, cross family confluence, and the top current signal, with a link back to this page. Post it, download it, or embed it anywhere.

Kresmion ABOS intelligence card preview
Post to X
LIVE TERMINAL

See ABOS live in the terminal

Track ABOS's insider trades, 13F flows, options positioning, and cross asset confluence as they update, on one live board. Free account.

Open the live ABOS terminal, free

Active signals for ABOS

FREE, NO ACCOUNT

Every signal on ABOS, as it fires

You are seeing 5 of 14 signals recorded on ABOS since 2026-05-16.

The five above landed across 2 days. The other 9 were recorded on 3 other days. 9 of the 14 are institutional flow rows, which arrive in batches on filing days.

Get it by email

No fixed schedule: it goes out when the data has something in it. Unsubscribe anytime. We never sell your data.

Join on Telegram
Join on Telegram

One tap. Live alerts, no email needed.

Largest reported share positions in ABOS (2026Q2)

Manager / securityMarket value% portfolioQoQ
RENAISSANCE TECHNOLOGIES LLCCUSIP 00509G209 · 2026Q2$1.8M0.00%,
TWO SIGMA INVESTMENTS, LPCUSIP 00509G209 · 2026Q2$1.7M0.00%,
MILLENNIUM MANAGEMENT LLCCUSIP 00509G209 · 2026Q2$162K0.00%,
CITADEL ADVISORS LLCCUSIP 00509G209 · 2026Q2$136K0.00%,

Quarterly SEC Form 13F disclosures from the managers Kresmion tracks, not a complete ownership ranking. Non-option holdings only; reported put and call positions are excluded. Different securities are labeled by CUSIP. Values are reporting-period snapshots, not current position values. Filings can arrive up to 45 days after quarter-end.

Recent SEC filings, ABOS

Related tickers

See more ABOS signals as they fire

Kresmion publishes filings, 13F flows, on-chain whale activity, and cross-asset signals in real time. Open a live board scoped to ABOSand get the insider, 13F, options, and confluence read in one view.

Open the live ABOS terminal, free